|
Market Closed -
Nasdaq
21:00:00 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 11.58 USD | +4.80% |
|
+3.12% | -9.81% |
| 10-14 | AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife IRE for Prostate and Liver Cancer | CI |
| 10-08 | Top Midday Decliners | MT |
| Market Cap | 487M 435M 404M 367M 691M 46.13B 704M 4.85B 1.9B 24.07B 1.83B 1.79B 77.01B | P/E 2027 * |
-17x | P/E 2028 * | -26.9x |
|---|---|---|---|---|---|
| Enterprise Value | 487M 435M 404M 367M 691M 46.13B 704M 4.85B 1.9B 24.07B 1.83B 1.79B 77.01B | EV / Sales 2027 * |
1.44x | EV / Sales 2028 * | 1.37x |
| Free-Float |
85.66% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANGO | Delayed | |
CBOE
| ANGO | Real-time | |
|
Deutsche Boerse AG
| UG2 | Delayed | |
|
Börse Stuttgart
| UG2 | Delayed | |
|
Boerse Muenchen
| UG2 | Real-time | |
|
Tradegate
| UG2 | Real-time |
Last Transcript: AngioDynamics, Inc.
| 1 day | +4.80% | ||
| 1 week | +3.12% | ||
| Current month | -24.71% | ||
| 1 month | -26.15% | ||
| 3 months | -19.97% | ||
| 6 months | +11.99% | ||
| Current year | -9.81% |
| 1 week | 10.62 |  | 11.7 |
| 1 month | 10.62 | | 15.88 |
| Current year | 9.39 | | 16.29 |
| 1 year | 9.39 | | 16.29 |
| 3 years | 5.26 | | 16.29 |
| 5 years | 5.26 | | 32 |
| 10 years | 5.26 | | 32 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Clemmer
CEO | Chief Executive Officer | 62 | 31/03/2016 |
| Director of Finance/CFO | 51 | 22/10/2019 | |
Juan Serna
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Howard Donnelly
CHM | Chairman | 65 | 28/04/2014 |
Wesley Johnson
BRD | Director/Board Member | 68 | 28/01/2007 |
James Clemmer
BRD | Director/Board Member | 62 | 31/03/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/07/26 | Sell | General Counsel | -23,370 | 0.0565% | ||
| 22/07/26 | Exercice | Executive/Senior Manager | 40,889 | 0.0990% | ||
| 22/07/26 | Exercice | General Counsel | 27,417 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.80% | +3.12% | -2.11% | +76.26% | 487M | |
| +1.66% | +6.28% | -19.13% | +15.20% | 181B | |
| +1.29% | +8.77% | +0.12% | +32.64% | 117B | |
| +4.12% | +5.87% | -20.70% | +13.71% | 112B | |
| +2.96% | +4.61% | -44.65% | -7.56% | 76.56B | |
| +1.56% | +6.24% | +6.82% | +80.66% | 65.15B | |
| +2.79% | +2.37% | +15.93% | +68.64% | 52.79B | |
| +2.58% | +6.02% | +3.74% | -25.10% | 52.78B | |
| +3.43% | +6.63% | -14.39% | +28.39% | 43.11B | |
| +1.78% | +2.32% | - | - | 32.08B | |
| Average | +2.18% | +4.87% | -8.26% | +31.43% | 73.34B | |
| Weighted average by Cap. | +1.56% | +5.70% | -11.89% | +23.31% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 338M 301M 280M 255M 479M 31.98B 488M 3.37B 1.32B 16.69B 1.27B 1.24B 53.4B | 355M 317M 294M 268M 504M 33.61B 513M 3.54B 1.38B 17.54B 1.33B 1.3B 56.12B |
| Net income | -28.86M -25.76M -23.94M -21.77M -40.97M -2.73B -41.7M -288M -113M -1.43B -108M -106M -4.56B | -18.19M -16.24M -15.09M -13.73M -25.83M -1.72B -26.29M -181M -70.93M -899M -68.27M -66.82M -2.88B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | US$11.58 | +4.80% | 1,137,016 |
| 14/10/26 | US$11.05 | +1.38% | 1,589,716 |
| 13/10/26 | US$10.90 | -4.39% | 1,345,983 |
| 12/10/26 | US$11.40 | -1.04% | 1,083,166 |
| 09/10/26 | US$11.52 | +2.58% | 2,156,139 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANGO Stock
Select your edition
All financial news and data tailored to specific country editions
